Evotec SE
XETRA:EVT
Evotec SE
Cash from Financing Activities
Evotec SE
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
E
|
Evotec SE
XETRA:EVT
|
Cash from Financing Activities
€72m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
8%
|
Gerresheimer AG
XETRA:GXI
|
Cash from Financing Activities
-€3.6m
|
CAGR 3-Years
64%
|
CAGR 5-Years
39%
|
CAGR 10-Years
17%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Cash from Financing Activities
-€11.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Evotec SE's Cash from Financing Activities?
Cash from Financing Activities
72m
EUR
Based on the financial report for Dec 31, 2023, Evotec SE's Cash from Financing Activities amounts to 72m EUR.
What is Evotec SE's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
8%
The average annual Cash from Financing Activities growth rates for Evotec SE have been -34% over the past three years , and 8% over the past ten years .